AAAAAA
Results:
1-22
|
Results: 22
Authors:
CHOLLET DF
GOUMAZ L
RENARD A
MONTAY G
VERNILLET L
ARNERA V
MAZZO DJ
Citation: Df. Chollet et al., SIMULTANEOUS DETERMINATION OF THE LACTONE AND CARBOXYLATE FORMS OF THE CAMPTOTHECIN DERIVATIVE CPT-11 AND ITS METABOLITE SN-38 IN PLASMA BYHIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical sciences and applications, 718(1), 1998, pp. 163-175
Authors:
LELIBOUX A
PASQUIER O
MONTAY G
Citation: A. Leliboux et al., SIMULTANEOUS HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OFQUINUPRISTIN, DALFOPRISTIN AND THEIR MAIN METABOLITES IN HUMAN PLASMA, Journal of chromatography B. Biomedical sciences and applications, 708(1-2), 1998, pp. 161-168
Authors:
PATAT A
KIRKESSELI S
LEFEBVRE P
CALIC F
MONTAY G
LECOZ F
GANDON JM
Citation: A. Patat et al., RILUZOLE SINGLE-DOSE PHARMACOKINETICS IN PATIENTS WITH IMPAIRED LIVER-FUNCTION, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 64-64
Authors:
BAILLE P
BRUNO R
SCHELLENS JHM
WEBSTER LK
MILLWARD M
VERWEIJ J
MONTAY G
Citation: P. Baille et al., OPTIMAL SAMPLING STRATEGIES FOR BAYESIAN-ESTIMATION OF DOCETAXEL (TAXOTERE) CLEARANCE, Clinical cancer research, 3(9), 1997, pp. 1535-1538
Authors:
BERGERON M
MONTAY G
Citation: M. Bergeron et G. Montay, THE PHARMACOKINETICS OF QUINUPRISTIN DALFOPRISTIN IN LABORATORY-ANIMALS AND IN HUMANS/, Journal of antimicrobial chemotherapy, 39, 1997, pp. 129-138
Authors:
LELIBOUX A
LEFEBVRE P
LEROUX Y
TRUFFINET P
AUBENEAU M
KIRKESSELI S
MONTAY G
Citation: A. Leliboux et al., SINGLE-DOSE AND MULTIPLE-DOSE PHARMACOKINETICS OF RILUZOLE IN WHITE SUBJECTS, Journal of clinical pharmacology, 37(9), 1997, pp. 820-827
Authors:
MARTINET M
MONTAY G
RHODES G
Citation: M. Martinet et al., PHARMACOKINETICS AND METABOLISM OF RILUZOLE, Medicamentos de actualidad, 33(8), 1997, pp. 587-594
Authors:
BRUNO R
VIVIER N
MONTAY G
LELIBOUX A
POWE LK
DELUMEAU JC
RHODES GR
Citation: R. Bruno et al., POPULATION PHARMACOKINETICS OF RILUZOLE IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS, Clinical pharmacology and therapeutics, 62(5), 1997, pp. 518-526
Authors:
BRUNO R
MONTAY G
POWE L
DELUMEAU JC
RHODES G
Citation: R. Bruno et al., POPULATION PHARMACOKINETICS OF RILUZOLE IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS (ALS), Clinical pharmacology and therapeutics, 61(2), 1997, pp. 83-83
Authors:
MONTAY G
Citation: G. Montay, PHARMACOKINETICS OF SPARFLOXACIN IN HEALTHY-VOLUNTEERS AND PATIENTS -A REVIEW, Journal of antimicrobial chemotherapy, 37, 1996, pp. 27-39
Authors:
URIEN S
BARRE J
MORIN C
PACCALY A
MONTAY G
TILLEMENT JP
Citation: S. Urien et al., DOCETAXEL SERUM-PROTEIN BINDING WITH HIGH-AFFINITY TO ALPHA(1)-ACID GLYCOPROTEIN, Investigational new drugs, 14(2), 1996, pp. 147-151
Authors:
BRUNO R
VIVIER N
VERGNIOL JC
DEPHILLIPS SL
MONTAY G
SHEINER LB
Citation: R. Bruno et al., A POPULATION PHARMACOKINETIC MODEL FOR DOCETAXEL (TAXOTERE(R)) - MODEL-BUILDING AND VALIDATION, Journal of pharmacokinetics and biopharmaceutics, 24(2), 1996, pp. 153-172
Authors:
CHEVALIER P
PACCALY A
BOURIOT JP
LEROUX Y
MONTAY G
THEBAULT JJ
CHASSARD D
PICHARD E
Citation: P. Chevalier et al., PHARMACOKINETIC OF PRISTINAMYCINS IN HEAL THY-VOLUNTEERS, Medecine et maladies infectieuses, 25(11), 1995, pp. 1153-1160
Authors:
BERTHAUD N
MONTAY G
CONARD BJ
DESNOTTES JF
Citation: N. Berthaud et al., BACTERICIDAL ACTIVITY AND KINETICS OF RP-59500 IN A MOUSE MODEL OF STAPHYLOCOCCUS-AUREUS SEPTICEMIA, Journal of antimicrobial chemotherapy, 36(2), 1995, pp. 365-373
Authors:
BERNARD E
BENSOUSSAN M
BENSOUSSAN F
ETIENNE S
CAZENAVE I
CARSENTIETESSE E
LEROUX Y
MONTAY G
DELLAMONICA P
Citation: E. Bernard et al., PHARMACOKINETICS AND SUCTION BLISTER FLUID PENETRATION OF A SEMISYNTHETIC INJECTABLE STREPTOGRAMIN RP-59500 (RP-57669 RP-54476), European journal of clinical microbiology & infectious diseases, 13(9), 1994, pp. 768-771
Authors:
PERAULT MC
CHAPELLE G
BOUQUET S
CHEVALIER P
MONTAY G
GAILLOT J
CHAKROUN H
GUILLET P
VANDEL B
Citation: Mc. Perault et al., PHARMACOKINETIC AND PHARMACODYNAMIC STUDY OF SURICLONE IMIPRAMINE INTERACTION IN MAN, Fundamental and clinical pharmacology, 8(3), 1994, pp. 251-255
Authors:
MONTAY G
BRUNO R
VERGNIOL JC
EBMEIER M
LEROUX Y
GUIMART C
FRYDMAN A
CHASSARD D
THEBAULT J
Citation: G. Montay et al., PHARMACOKINETICS OF SPARFLOXACIN IN HUMANS AFTER SINGLE ORAL-ADMINISTRATION AT DOSES OF 200-MG, 400-MG, 600-MG, AND 800-MG, Journal of clinical pharmacology, 34(11), 1994, pp. 1071-1076
Authors:
FILLASTRE JP
MONTAY G
BRUNO R
ETIENNE I
DHIB M
VIVIER N
LEROUX Y
GUIMART C
GAY G
SCHOTT D
Citation: Jp. Fillastre et al., PHARMACOKINETICS OF SPARFLOXACIN IN PATIENTS WITH RENAL IMPAIRMENT, Antimicrobial agents and chemotherapy, 38(4), 1994, pp. 733-737
Authors:
CHEVALIER P
ROUILLARD C
MONTAY G
FRYDMAN A
Citation: P. Chevalier et al., APRIKALIM - RADIOIMMUNOASSAY AND PHARMACOKINETIC STUDIES IN MOUSE, MONKEY, AND DOG, Journal of pharmaceutical sciences, 83(3), 1994, pp. 372-378
Authors:
BRUNO R
DORR MB
MONTAY G
FRYDMAN A
THIS F
FUMOLEAU P
KAY S
KAVANAGH GH
BURRIS HA
RIGAS JR
BAYSSAS M
Citation: R. Bruno et al., DESIGN AND PROSPECTIVE IMPLEMENTATION OF POPULATION PHARMACOKINETIC STUDIES DURING THE DEVELOPMENT OF DOCETAXEL (D) (RP-56976) - A NEW ANTICANCER DRUG, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 161-161
Authors:
TENENBAUM H
CUISINIER FJG
LELIBOUX A
PICHARD E
MONTAY G
FRYDMAN A
Citation: H. Tenenbaum et al., SECNIDAZOLE CONCENTRATIONS IN PLASMA AND CREVICULAR FLUID AFTER A SINGLE ORAL DOSE, Journal of clinical periodontology, 20(7), 1993, pp. 505-508
Authors:
BRUNO R
ILIADIS MC
LACARELLE B
COSSON V
MANDEMA JW
LEROUX Y
MONTAY G
DURAND A
BALLEREAU M
ALASIA M
ALBANESE J
FRANCOIS G
ILIADIS A
FRYDMAN A
Citation: R. Bruno et al., EVALUATION OF BAYESIAN-ESTIMATION IN COMPARISON TO NONMEM FOR POPULATION PHARMACOKINETIC DATA-ANALYSIS - APPLICATION TO PEFLOXACIN IN INTENSIVE-CARE UNIT PATIENTS, Journal of pharmacokinetics and biopharmaceutics, 20(6), 1992, pp. 653-669
Risultati:
1-22
|